ketamine has been researched along with Bone Cancer in 8 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To improve opioid repsonse in patients with movement-related pain by using opioid switching adding a burst of ketamine." | 7.75 | Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. ( Arcuri, E; David, F; Ferrera, P; Mercadante, S; Villari, P, 2009) |
| "Not all bone cancer pain can be effectively treated with current therapies." | 5.33 | Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain. ( Aoe, T; Kozikowski, A; Neale, JH; Saito, O; Sarva, J; Yamamoto, T, 2006) |
| "To improve opioid repsonse in patients with movement-related pain by using opioid switching adding a burst of ketamine." | 3.75 | Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. ( Arcuri, E; David, F; Ferrera, P; Mercadante, S; Villari, P, 2009) |
| "No patient had hallucinations." | 2.73 | Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic-oncological patients. ( Bickels, J; Chazan, S; Kollender, Y; Maruoani, N; Meller, I; Nirkin, A; Stocki, D; Weinbroum, AA, 2008) |
| "Pain is the primary problem targeted for control using the World Health Organization's (WHO) analgesic ladder." | 2.41 | Advances in cancer pain management. ( Hamann, SR; McDonnell, FJ; Sloan, JW, 2000) |
| "A 42 year-old woman with breast cancer and major depression resistant to medical treatment received a 90 minute intravenous infusion of 0." | 1.39 | [Effect of sub-anaesthetic doses of ketamine in the postoperative period in a patient with uncontrolled depression]. ( Alférez-García, I; Alonso-Menoyo, MB; Carricondo-Martínez, MA; Cortiñas-Saenz, M; Errando-Oyonarte, CL, 2013) |
| "Not all bone cancer pain can be effectively treated with current therapies." | 1.33 | Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain. ( Aoe, T; Kozikowski, A; Neale, JH; Saito, O; Sarva, J; Yamamoto, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mercadante, S | 1 |
| Villari, P | 1 |
| Ferrera, P | 1 |
| Arcuri, E | 1 |
| David, F | 1 |
| Cortiñas-Saenz, M | 1 |
| Alonso-Menoyo, MB | 1 |
| Errando-Oyonarte, CL | 1 |
| Alférez-García, I | 1 |
| Carricondo-Martínez, MA | 1 |
| Shimazaki, M | 1 |
| Egawa, H | 1 |
| Motojima, F | 1 |
| Fujimaki, K | 1 |
| Hamaguchi, S | 1 |
| Okuda, Y | 1 |
| Kitajima, T | 1 |
| Shimoyama, N | 1 |
| Akizuki, A | 1 |
| Takahashi, H | 1 |
| Shimoyama, M | 1 |
| Saito, O | 1 |
| Aoe, T | 1 |
| Kozikowski, A | 1 |
| Sarva, J | 1 |
| Neale, JH | 1 |
| Yamamoto, T | 1 |
| Kollender, Y | 1 |
| Bickels, J | 1 |
| Stocki, D | 1 |
| Maruoani, N | 1 |
| Chazan, S | 1 |
| Nirkin, A | 1 |
| Meller, I | 1 |
| Weinbroum, AA | 1 |
| McDonnell, FJ | 1 |
| Sloan, JW | 1 |
| Hamann, SR | 1 |
| Wyant, GM | 1 |
2 reviews available for ketamine and Bone Cancer
| Article | Year |
|---|---|
[Palliative medicine for advanced gynecological malignancy].
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Bone Neoplasms; Drug Therapy, | 2004 |
Advances in cancer pain management.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Bone Diseases; Bone Neoplasms; Chemothe | 2000 |
1 trial available for ketamine and Bone Cancer
| Article | Year |
|---|---|
Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic-oncological patients.
Topics: Adolescent; Adult; Aged; Analgesics; Analysis of Variance; Bone Neoplasms; Double-Blind Method; Drug | 2008 |
5 other studies available for ketamine and Bone Cancer
| Article | Year |
|---|---|
Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Bone Neoplasms; Humans; Ketamine; Male; Middle Aged; | 2009 |
[Effect of sub-anaesthetic doses of ketamine in the postoperative period in a patient with uncontrolled depression].
Topics: Adenocarcinoma; Analgesics; Antidepressive Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; | 2013 |
[Intrathecal phenol block in a child with cancer pain--a case report].
Topics: Adolescent; Analgesics, Opioid; Anesthesia, Spinal; Bone Neoplasms; Humans; Injections, Intravenous; | 2003 |
Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain.
Topics: Adrenergic alpha-Agonists; Analgesia; Animals; Bone Neoplasms; Dexmedetomidine; Dizocilpine Maleate; | 2006 |
Intramuscular ketalar (CI-581) in paediatric anaesthesia.
Topics: Age Factors; Analgesics; Anesthesia, General; Blood Pressure; Bone Neoplasms; Child; Child, Preschoo | 1971 |